Global Peptide Therapeutics Market: Industry Analysis and Forecast (2020-2026) By Type, Application, Route of Administration and Region

Global Peptide Therapeutics Market is expected to reach US$ XX Mn by 2026 from $XX Mn in 2019, at a CAGR of 9.5% during the forecast period.

Global Peptide Therapeutics Market Overview:

Peptides are known for their high selectivity and efficacy while still being relatively safe and well-tolerated. As a result, peptides are receiving more attention in pharmaceutical research and development (R&D), with approximately 140 peptide therapeutics currently undergoing clinical trials.

Global Peptide Therapeutics Market Dynamics:

The use of peptide molecules in the development of the COVID-19 vaccine is expected to increase, which will boost the market growth. Vaxil announced the creation of a vaccine based on a proprietary signal peptide (SP) discovered using a bioinformatics tool in 2020. This strategy allows for the development of targeted therapies against cancer or infectious disease pathogens by using signal peptide domains on critical proteins. Government funding for the use of peptides in the production of the COVID-19 vaccine is expected to provide a potential incentive for peptide adoption, which will potentially stimulate the growth of the peptide therapeutics market. Growing cases of metabolic and infectious disorders are expected to stimulate market growth during the forecast period. The Centers for Disease Control and Prevention (CDC) states that about 34.2 million people in the United States were diagnosed with diabetes in 2020. Furthermore, the prevalence of diabetes continues to rise in comparison to previous decades, according to the same research. Diseases such as brain disorders and cancers are becoming more prevalent, resulting in higher healthcare costs. Countries that are experiencing economic difficulties are more likely to implement cost-effective and reliable peptide therapeutics in order to reduce their healthcare costs. The American Cancer Society’s study suggests that there will be 1.8 million new cancer cases diagnosed and 606,520 cancer deaths in the United States in 2020. The public awareness of peptide therapeutics and the implementation of favorable reimbursement policies by governments around the world are likely to influence consumers and doctors to seek out cost-effective therapeutic peptides in order to introduce experimental drugs for the treatment of serious disorders. The global peptide therapeutics market is expected to be hampered by natural peptides' poor chemical and physical stability, as well as their limited circulating plasma half-life. However, since peptide drugs are administered by injection, low oral availability, and poor penetration of the intestinal mucosa are expected to limit market growth in the near future. The development of new peptides are expected to provide lucrative growth opportunities for market players. CohBar, Inc., in 2019 announced new preclinical evidence that demonstrated the therapeutic potential of a novel CohBar peptide in a preclinical model of Idiopathic Pulmonary Fibrosis (IPF). The report has profiled eighteen key players in the market from different regions. However, the report has considered all market leaders, followers and new entrants with investors while analyzing the market and estimation the size of the same. Increasing R&D activities in each region are different and focus is given on the regional impact on the cost, availability of advanced technology are analyzed and report has come up with recommendations for a future hot spot in APAC region.

Global Peptide Therapeutics Market Segment Analysis:

The Global Peptide Therapeutics Market is segmented on the basis of Type, Application and Route of Administration. Based on Type, the branded segment held the largest market share in 2019. The segment growth is attributed to factors such as major pharmaceutical companies growing investments in R&D for the production of new drugs and high prescription rates. Generics, on the other hand, are expected to rise at a healthy rate over the forecast period. The use of generics is expected to be accelerated by rising healthcare spending and increased healthcare spending by the federal government. Based on the Application, the cancer segment is expected to dominate the global market during the forecast period. The main factors driving this segment's dominance are an increase in the global incidence of cancer and an increase in the prescription of peptide therapeutics for cancer care. The growing demand for effective and fast-acting therapeutics is expected to boost growth even further. The growing demand for effective and fast-acting therapeutics is expected to boost growth even further. Patients and healthcare practitioners are becoming more mindful of the negative effects of chemotherapy and radiation therapy, which is leading to a greater emphasis on alternative therapeutics such as peptide-based medications. Global Peptide Therapeutics Market To know about the Research Methodology :- Request Free Sample Report

Global Peptide Therapeutics Market Regional Insights:

Global Peptide Therapeutics Market Regional Insights North America is expected to dominate the global market. The market in North America is anticipated to dominate as a result of factors such as increased understanding of peptide therapeutics, the growing need for diagnostics in cancer and other diseases, and the expanding biotechnology industry. Increased government and industry spending on research and development is also expected to help peptide therapeutics maintain their supremacy in the coming years. Another factor such as the well-established biopharmaceutical and pharmaceutical industry in this region is a major driver of growth. Asia Pacific is expected to witness lucrative growth during the forecast period. Over the forecast period, the Asia-Pacific peptide therapeutics market is expected to expand significantly, owing to rising biotech companies and government healthcare spending, as well as the rising prevalence of cancer and nervous system disorders. These factors are anticipated to impact positively on the market growth in APAC. The report also helps in understanding the Global Peptide Therapeutics Market dynamics, structure by analyzing the market segments and project the Global Peptide Therapeutics Market size. Clear representation of competitive analysis of key players by product, price, financial position, product portfolio, growth strategies, and regional presence in the Global Peptide Therapeutics Market make the report investor’s guide.

Global Peptide Therapeutics Market Key Developments:

• Bioniz Therapeutics Inc., a clinical-stage biopharmaceutical company developing first-in-class peptide treatments for immuno-inflammatory diseases, was acquired by Almirall, S.A. in January 2020. • Zealand Pharma A/S, a Copenhagen-based biotechnology company focusing on the discovery and production of novel peptide-based medicines, announced the acquisition of Encycle Therapeutics, Inc., a private Toronto-based biotech company with a unique platform technology that enables the rapid synthesis of macrocyclic peptides with enhanced drug-like properties, in October 2019.

Global Peptide Therapeutics Market Scope: Inquire before buying

Global Peptide Therapeutics Market

Global Peptide Therapeutics Market, by Region

• North America • Europe • South America • MEA • APAC

Global Peptide Therapeutics Market Key Players

• Eli Lilly and Company • Amgen Inc. • TEVA PHARMACEUTICAL INDUSTRIES LTD • Polypeptide Group • EVER Pharma GmbH • Bristol-Myers Squibb Company • Novo Nordisk A/S • Sanofi • AstraZeneca PLC • Glaxosmithkline PLC • Pfizer, Inc. • Takeda Pharmaceutical Company Limited • Lonza Inc • Novartis AG • Bachem Holding AG • CordenPharma International • Ipsen S.A • Merck & Co., Inc
1.Preface 1.1. Market Definition and Key Research Objectives 1.2. Research Highlights 2. Assumptions and Research Methodology 2.1. Report Assumptions 2.2. Abbreviations 2.3. Research Methodology 2.3.1. Secondary Research 2.3.1.1. Secondary data 2.3.1.2. Secondary Sources 2.3.2. Primary Research 2.3.2.1. Data from Primary Sources 2.3.2.2. Breakdown of Primary Sources 3. Executive Summary: Global Peptide Therapeutics Market Size, by Market Value (US$ Mn) 3.1. Global Market Segmentation 3.2. Global Market Segmentation Share Analysis, 2019 3.2.1. Global 3.2.2. By Region (North America, Europe, Asia Pacific, South America, Middle East Africa) 3.3. Geographical Snapshot of the Peptide Therapeutics Market 3.4. Geographical Snapshot of the Peptide Therapeutics Market, By Manufacturer share 4. Global Peptide Therapeutics Market Overview, 2019-2026 4.1. Market Dynamics 4.1.1. Drivers 4.1.1.1. Global 4.1.1.2. By Region (North America, Europe, Asia Pacific, South America, Middle East Africa) 4.1.2. Restraints 4.1.2.1. Global 4.1.2.2. By Region (North America, Europe, Asia Pacific, South America, Middle East Africa) 4.1.3. Opportunities 4.1.3.1. Global 4.1.3.2. By Region (North America, Europe, Asia Pacific, South America, Middle East Africa) 4.1.4. Challenges 4.1.4.1. Global 4.1.4.2. By Region (North America, Europe, Asia Pacific, South America, Middle East Africa) 4.1.5. Industry Trends and Emerging Technologies 4.1.6. Porters Five Forces Analysis 4.1.6.1. Threat of New Entrants 4.1.6.2. Bargaining Power of Buyers/Consumers 4.1.6.3. Bargaining Power of Suppliers 4.1.6.4. Threat of Substitute Products 4.1.6.5. Intensity of Competitive Rivalry 4.1.7. Value Chain Analysis 4.1.8. Technological Roadmap 4.1.9. Regulatory landscape 4.1.10. Impact of the Covid-19 Pandemic on the Global Peptide Therapeutics Market 5. Supply Side and Demand Side Indicators 6. Global Peptide Therapeutics Market Analysis and Forecast, 2019-2026 6.1. Global Peptide Therapeutics Market Size & Y-o-Y Growth Analysis. 7. Global Peptide Therapeutics Market Analysis and Forecasts, 2019-2026 7.1. Market Size (Value) Estimates & Forecast By Type, 2019-2026 7.1.1. Generic 7.1.2. Branded 7.2. Market Size (Value) Estimates & Forecast By Application, 2019-2026 7.2.1. Gastrointestinal Disorders 7.2.2. Neurological Disorders 7.2.3. Metabolic Disorders 7.2.4. Cancer 7.2.5. Other Applications 7.3. Market Size (Value) Estimates & Forecast By Route of Administration, 2019-2026 7.3.1. Parenteral 7.3.2. Oral 8. Global Peptide Therapeutics Market Analysis and Forecasts, By Region 8.1. Market Size (Value) Estimates & Forecast By Region, 2019-2026 8.1.1. North America 8.1.2. Europe 8.1.3. Asia-Pacific 8.1.4. Middle East & Africa 8.1.5. South America 9. North America Peptide Therapeutics Market Analysis and Forecasts, 2019-2026 9.1. Market Size (Value) Estimates & Forecast By Type, 2019-2026 9.1.1. Generic 9.1.2. Branded 9.2. Market Size (Value) Estimates & Forecast By Application, 2019-2026 9.2.1. Gastrointestinal Disorders 9.2.2. Neurological Disorders 9.2.3. Metabolic Disorders 9.2.4. Cancer 9.2.5. Other Applications 9.3. Market Size (Value) Estimates & Forecast By Route of Administration, 2019-2026 9.3.1. Parenteral 9.3.2. Oral 10. North America Peptide Therapeutics Market Analysis and Forecasts, By Country 10.1. Market Size (Value) Estimates & Forecast By Country, 2019-2026 10.1.1. US 10.1.2. Canada 10.1.3. Mexico 11. U.S. Peptide Therapeutics Market Analysis and Forecasts, 2019-2026 11.1. Market Size (Value) Estimates & Forecast By Type, 2019-2026 11.2. Market Size (Value) Estimates & Forecast By Application, 2019-2026 11.3. Market Size (Value) Estimates & Forecast By Route of Administration, 2019-2026 12. Canada Peptide Therapeutics Market Analysis and Forecasts, 2019-2026 12.1. Market Size (Value) Estimates & Forecast By Type, 2019-2026 12.2. Market Size (Value) Estimates & Forecast By Application, 2019-2026 12.3. Market Size (Value) Estimates & Forecast By Route of Administration, 2019-2026 13. Mexico Peptide Therapeutics Market Analysis and Forecasts, 2019-2026 13.1. Market Size (Value) Estimates & Forecast By Type, 2019-2026 13.2. Market Size (Value) Estimates & Forecast By Application, 2019-2026 13.3. Market Size (Value) Estimates & Forecast By Route of Administration, 2019-2026 14. Europe Peptide Therapeutics Market Analysis and Forecasts, 2019-2026 14.1. Market Size (Value) Estimates & Forecast By Type, 2019-2026 14.2. Market Size (Value) Estimates & Forecast By Application, 2019-2026 14.3. Market Size (Value) Estimates & Forecast By Route of Administration, 2019-2026 15. Europe Peptide Therapeutics Market Analysis and Forecasts, By Country 15.1. Market Size (Value) Estimates & Forecast By Country, 2019-2026 15.1.1. U.K 15.1.2. France 15.1.3. Germany 15.1.4. Italy 15.1.5. Spain 15.1.6. Sweden 15.1.7. CIS Countries 15.1.8. Rest of Europe 16. U.K. Peptide Therapeutics Market Analysis and Forecasts, 2019-2026 16.1. Market Size (Value) Estimates & Forecast By Type, 2019-2026 16.2. Market Size (Value) Estimates & Forecast By Application, 2019-2026 16.3. Market Size (Value) Estimates & Forecast By Route of Administration, 2019-2026 17. France Peptide Therapeutics Market Analysis and Forecasts, 2019-2026 17.1. Market Size (Value) Estimates & Forecast By Type, 2019-2026 17.2. Market Size (Value) Estimates & Forecast By Application, 2019-2026 17.3. Market Size (Value) Estimates & Forecast By Route of Administration, 2019-2026 18. Germany Peptide Therapeutics Market Analysis and Forecasts, 2019-2026 18.1. Market Size (Value) Estimates & Forecast By Type, 2019-2026 18.2. Market Size (Value) Estimates & Forecast By Application, 2019-2026 18.3. Market Size (Value) Estimates & Forecast By Route of Administration, 2019-2026 19. Italy Peptide Therapeutics Market Analysis and Forecasts, 2019-2026 19.1. Market Size (Value) Estimates & Forecast By Type, 2019-2026 19.2. Market Size (Value) Estimates & Forecast By Application, 2019-2026 19.3. Market Size (Value) Estimates & Forecast By Route of Administration, 2019-2026 20. Spain Peptide Therapeutics Market Analysis and Forecasts, 2019-2026 20.1. Market Size (Value) Estimates & Forecast By Type, 2019-2026 20.2. Market Size (Value) Estimates & Forecast By Application, 2019-2026 20.3. Market Size (Value) Estimates & Forecast By Route of Administration, 2019-2026 21. Sweden Peptide Therapeutics Market Analysis and Forecasts, 2019-2026 21.1. Market Size (Value) Estimates & Forecast By Type, 2019-2026 21.2. Market Size (Value) Estimates & Forecast By Application, 2019-2026 21.3. Market Size (Value) Estimates & Forecast By Route of Administration, 2019-2026 22. CIS Countries Peptide Therapeutics Market Analysis and Forecasts, 2019-2026 22.1. Market Size (Value) Estimates & Forecast By Type, 2019-2026 22.2. Market Size (Value) Estimates & Forecast By Application, 2019-2026 22.3. Market Size (Value) Estimates & Forecast By Route of Administration, 2019-2026 23. Rest of Europe Peptide Therapeutics Market Analysis and Forecasts, 2019-2026 23.1. Market Size (Value) Estimates & Forecast By Type, 2019-2026 23.2. Market Size (Value) Estimates & Forecast By Application, 2019-2026 23.3. Market Size (Value) Estimates & Forecast By Route of Administration, 2019-2026 24. Asia Pacific Peptide Therapeutics Market Analysis and Forecasts, 2019-2026 24.1. Market Size (Value) Estimates & Forecast By Type, 2019-2026 24.2. Market Size (Value) Estimates & Forecast By Application, 2019-2026 24.3. Market Size (Value) Estimates & Forecast By Route of Administration, 2019-2026 25. Asia Pacific Peptide Therapeutics Market Analysis and Forecasts, by Country 25.1. Market Size (Value) Estimates & Forecast By Country, 2019-2026 25.1.1. China 25.1.2. India 25.1.3. Japan 25.1.4. South Korea 25.1.5. Australia 25.1.6. ASEAN 25.1.7. Rest of Asia Pacific 26. China Peptide Therapeutics Market Analysis and Forecasts, 2019-2026 26.1. Market Size (Value) Estimates & Forecast By Type, 2019-2026 26.2. Market Size (Value) Estimates & Forecast By Application, 2019-2026 26.3. Market Size (Value) Estimates & Forecast By Route of Administration, 2019-2026 27. India Peptide Therapeutics Market Analysis and Forecasts, 2019-2026 27.1. Market Size (Value) Estimates & Forecast By Type, 2019-2026 27.2. Market Size (Value) Estimates & Forecast By Application, 2019-2026 27.3. Market Size (Value) Estimates & Forecast By Route of Administration, 2019-2026 28. Japan Peptide Therapeutics Market Analysis and Forecasts, 2019-2026 28.1. Market Size (Value) Estimates & Forecast By Type, 2019-2026 28.2. Market Size (Value) Estimates & Forecast By Application, 2019-2026 28.3. Market Size (Value) Estimates & Forecast By Route of Administration, 2019-2026 29. South Korea Peptide Therapeutics Market Analysis and Forecasts, 2019-2026 29.1. Market Size (Value) Estimates & Forecast By Type, 2019-2026 29.2. Market Size (Value) Estimates & Forecast By Application, 2019-2026 29.3. Market Size (Value) Estimates & Forecast By Route of Administration, 2019-2026 30. Australia Peptide Therapeutics Market Analysis and Forecasts, 2019-2026 30.1. Market Size (Value) Estimates & Forecast By Type, 2019-2026 30.2. Market Size (Value) Estimates & Forecast By Application, 2019-2026 30.3. Market Size (Value) Estimates & Forecast By Route of Administration, 2019-2026 31. ASEAN Peptide Therapeutics Market Analysis and Forecasts, 2019-2026 31.1. Market Size (Value) Estimates & Forecast By Type, 2019-2026 31.2. Market Size (Value) Estimates & Forecast By Application, 2019-2026 31.3. Market Size (Value) Estimates & Forecast By Route of Administration, 2019-2026 32. Rest of Asia Pacific Peptide Therapeutics Market Analysis and Forecasts, 2019-2026 32.1. Market Size (Value) Estimates & Forecast By Type, 2019-2026 32.2. Market Size (Value) Estimates & Forecast By Application, 2019-2026 32.3. Market Size (Value) Estimates & Forecast By Route of Administration, 2019-2026 33. Middle East Africa Peptide Therapeutics Market Analysis and Forecasts, 2019-2026 33.1. Market Size (Value) Estimates & Forecast By Type, 2019-2026 33.2. Market Size (Value) Estimates & Forecast By Application, 2019-2026 33.3. Market Size (Value) Estimates & Forecast By Route of Administration, 2019-2026 34. Middle East Africa Peptide Therapeutics Market Analysis and Forecasts, by Country 34.1. Market Size (Value) Estimates & Forecast by Country, 2019-2026 34.1.1. South Africa 34.1.2. GCC Countries 34.1.3. Egypt 34.1.4. Nigeria 34.1.5. Rest of ME&A 35. South Africa Peptide Therapeutics Market Analysis and Forecasts, 2019-2026 35.1. Market Size (Value) Estimates & Forecast By Type, 2019-2026 35.2. Market Size (Value) Estimates & Forecast By Application, 2019-2026 35.3. Market Size (Value) Estimates & Forecast By Route of Administration, 2019-2026 36. GCC Countries Peptide Therapeutics Market Analysis and Forecasts, 2019-2026 36.1. Market Size (Value) Estimates & Forecast By Type, 2019-2026 36.2. Market Size (Value) Estimates & Forecast By Application, 2019-2026 36.3. Market Size (Value) Estimates & Forecast By Route of Administration, 2019-2026 37. Egypt Peptide Therapeutics Market Analysis and Forecasts, 2019-2026 37.1. Market Size (Value) Estimates & Forecast By Type, 2019-2026 37.2. Market Size (Value) Estimates & Forecast By Application, 2019-2026 37.3. Market Size (Value) Estimates & Forecast By Route of Administration, 2019-2026 38. Nigeria Peptide Therapeutics Market Analysis and Forecasts, 2019-2026 38.1. Market Size (Value) Estimates & Forecast By Type, 2019-2026 38.2. Market Size (Value) Estimates & Forecast By Application, 2019-2026 38.3. Market Size (Value) Estimates & Forecast By Route of Administration, 2019-2026 39. Rest of ME&A Peptide Therapeutics Market Analysis and Forecasts, 2019-2026 39.1. Market Size (Value) Estimates & Forecast By Type, 2019-2026 39.2. Market Size (Value) Estimates & Forecast By Application, 2019-2026 39.3. Market Size (Value) Estimates & Forecast By Route of Administration, 2019-2026 40. South America Peptide Therapeutics Market Analysis and Forecasts, 2019-2026 40.1. Market Size (Value) Estimates & Forecast By Type, 2019-2026 40.2. Market Size (Value) Estimates & Forecast By Application, 2019-2026 40.3. Market Size (Value) Estimates & Forecast By Route of Administration, 2019-2026 41. South America Peptide Therapeutics Market Analysis and Forecasts, by Country 41.1. Market Size (Value) Estimates & Forecast by Country, 2019-2026 41.1.1. Brazil 41.1.2. Argentina 41.1.3. Rest of South America 42. Brazil Peptide Therapeutics Market Analysis and Forecasts, 2019-2026 42.1. Market Size (Value) Estimates & Forecast By Type, 2019-2026 42.2. Market Size (Value) Estimates & Forecast By Application, 2019-2026 42.3. Market Size (Value) Estimates & Forecast By Route of Administration, 2019-2026 43. Argentina Peptide Therapeutics Market Analysis and Forecasts, 2019-2026 43.1. Market Size (Value) Estimates & Forecast By Type, 2019-2026 43.2. Market Size (Value) Estimates & Forecast By Application, 2019-2026 43.3. Market Size (Value) Estimates & Forecast By Route of Administration, 2019-2026 44. Rest of South America Peptide Therapeutics Market Analysis and Forecasts, 2019-2026 44.1. Market Size (Value) Estimates & Forecast By Type, 2019-2026 44.2. Market Size (Value) Estimates & Forecast By Application, 2019-2026 44.3. Market Size (Value) Estimates & Forecast By Route of Administration, 2019-2026 45. Competitive Landscape 45.1. Geographic Footprint of Major Players in the Global Peptide Therapeutics Market 45.2. Competition Matrix 45.2.1. Competitive Benchmarking of Key Players By Price, Presence, Market Share, Applications and R&D Investment 45.2.2. New Product Launches and Product Enhancements 45.2.3. Market Consolidation 45.2.3.1. M&A by Regions, Investment and Verticals 45.2.3.2. M&A, Forward Integration and Backward Integration 45.2.3.3. Partnership, Joint Ventures and Strategic Alliances/ Sales Agreements 45.3. Company Profile : Key Players 45.3.1. Eli Lilly and Company 45.3.1.1. Company Overview 45.3.1.2. Financial Overview 45.3.1.3. Geographic Footprint 45.3.1.4. Product Portfolio 45.3.1.5. Business Strategy 45.3.1.6. Recent Developments 45.3.2. Amgen Inc. 45.3.3. TEVA PHARMACEUTICAL INDUSTRIES LTD 45.3.4. Polypeptide Group 45.3.5. EVER Pharma GmbH 45.3.6. Bristol-Myers Squibb Company 45.3.7. Novo Nordisk A/S 45.3.8. Sanofi 45.3.9. AstraZeneca PLC 45.3.10. Glaxosmithkline PLC 45.3.11. Pfizer, Inc. 45.3.12. Takeda Pharmaceutical Company Limited 45.3.13. Lonza Inc 45.3.14. Novartis AG 45.3.15. Bachem Holding AG 45.3.16. CordenPharma International 45.3.17. Ipsen S.A 45.3.18. Merck & Co., Inc. 46. Primary Key Insights

About This Report

Report ID101400
Category Healthcare
Published DateMay 2021
Updated Date
Contact Us